EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.6.2.4 | alpha-lipoic acid | 17% inhibition at 5.0 mM | Homo sapiens | |
1.6.2.4 | Ethacrynic acid | 64% inhibition at 1.0 mM | Homo sapiens | |
1.6.2.4 | menadione | 85% inhibition at 0.2 mM | Homo sapiens | |
1.6.2.4 | additional information | no significant inhibition by diphenyleneiodonium chloride, flufenamic acid, and 18beta-glycyrrhetinic acid | Homo sapiens | |
1.6.2.4 | phenolphthaleine | 13% inhibition at 0.02 mM | Homo sapiens | |
1.6.2.4 | quercetin | 48% inhibition at 0.2 mM | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.6.2.4 | microsome | - |
Homo sapiens | - |
- |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.6.2.4 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.6.2.4 | NADPH + H+ + 1-[3-(4-phenoxyphenoxy)-2-oxopropyl]indole-5-carboxylic acid | - |
Homo sapiens | NADP+ + 1-[2-hydroxy-3-(4-phenoxyphenoxy)propyl]indole-5-carboxylic acid | - |
? | |
1.6.2.4 | NADPH + H+ + daunorubicin | - |
Homo sapiens | NADP+ + ? | - |
? | |
1.6.2.4 | NADPH + H+ + haloperidol | - |
Homo sapiens | NADP+ + ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.6.2.4 | NADPH-CYP450 reductase | - |
Homo sapiens |
1.6.2.4 | NADPH-cytochrome P450 reductase | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.6.2.4 | FAD | - |
Homo sapiens | |
1.6.2.4 | FMN | - |
Homo sapiens |